Rita Mariangela Murru

Pubblicazioni

Titolo Pubblicato in Anno
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib? BLOOD ADVANCES 2021
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study LEUKEMIA 2020
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience BRITISH JOURNAL OF HAEMATOLOGY 2019
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 CANCERS 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma